Medtronic Announces FDA Approval of Minimally Invasive Device to Treat Hypertension
Approval is the culmination of 10 years of clinical research and development of the Medtronic renal denervation technology
Source: dicardiology.com
Global Clinical Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Global Clinical Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Global Clinical Program Today - Breaking & Trending Today
FDA OKs Symplicity Renal Denervation System for Hypertension
After a mixed FDA panel review in August, the agency has approved Medtronic's Symplicity Spyral renal denervation system for treatment of hypertension.
Source: medscape.com
Medtronic announces FDA approval of minimally invasive device to treat hypertension
The Symplicity™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure Approval is the culmination of ten years of clinical research and development of the...
Source: marketscreener.com
Medtronic issues statement on the FDA Circulatory Systems Devices Advisory Panel vote for the Symplicity Spyral Renal Denervation System
/PRNewswire/ -- Today, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review...
Source: prnewswire.com
EuroPCR: Medtronic renal denervation system shows better blood pressure control with significantly more time in target range
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com